Skip to main content
. 2021 Dec 17;8:733602. doi: 10.3389/fnut.2021.733602

Table 4.

Biomarker iodine concentrations in gestational week 29 (GW29) and at 4 months postpartum (4M) grouped by the use of iodized table salt.

Biomarker n Non-iodized table salt and/or non-table salt1 (n = 65) n Mix of iodized table salt and other (n = 141) n Solely iodized table salt (n = 247) p
Median (25−75th) Median (25−75th) Median (25–75th)
IODINE
Maternal urine, μg/L (GW29)2 63 106 (74–134)a 138 113 (81–175) 242 117 (83–176)a 0.095
Breast milk, μg/kg (4M) 37 53 (40–117) 90 73 (50–115) 154 78 (54–119) 0.245
Infant urine, μg/L (4M)3 44 102 (58–146) 85 115 (92–145) 170 115 (81–155) 0.221
    Breastfed 28 85 (51–144)a 53 114 (85–142) 108 115 (80–171)a 0.074
    Not breastfed4 16 117 (85–161) 32 117 (95–153) 62 114 (87–137) 0.739

Differences between salt groups were tested with Kruskal-Wallis test and presented with p-values. Test between two groups per time was made with Mann-Whitney U test and significant differences between groups are presented with matching letters in superscript.

1

Non-Table Salt includes use of Flake Salt/Coarse sea Salt, Rock Salt (e.g., Himalayan Salt), Mineral Salt (low in Sodium e.g., Seltin) or Other Salt.

2

Adjusted to the mothers mean urinary specific gravity (SGmean = 1.017).

3

Adjusted to the infants mean urinary specific gravity (SGmean = 1.004).

4

Estimated based on available breast milk sample at 4 months or not, regardless of reported extent.